Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
A GPBAR1 (TGR5) Small Molecule Agonist Shows Specific Inhibitory Effects on Myeloid Cell Activation In Vitro and Reduces Experimental Autoimmune Encephalitis (EAE) In Vivo.
Epidemiological, humanistic, and economic burden of illness of lower limb spasticity in adults: a systematic review.
Cortical N-acetyl aspartate is a predictor of long-term clinical disability in multiple sclerosis.
Dehydration affects spinal cord cross-sectional area measurement on MRI in healthy subjects.
Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial.
Ultra-high-field MR imaging in multiple sclerosis.
Synthesis of 1,4-anthracene-9,10-dione derivatives and their regulation of nitric oxide, IL-1β and TNF-α in activated RAW264.7 cells.
OnabotulinumtoxinA is Effective in Patients with Urinary Incontinence due to Neurogenic Detrusor Activity Regardless of Concomitant Anticholinergic Use or Neurologic Etiology.
New insights in the pathogenesis of multiple sclerosis-role of acrolein in neuronal and myelin damage.
The effect of exercise training on fitness in multiple sclerosis: A meta-analysis.
Bone health in patients with multiple sclerosis relapses.
Functional impairments in white matter syndrome of neuropsychiatric systemic lupus erythematosus are similar to those observed in patients with multiple sclerosis.
Contribution of CD8 T lymphocytes to the immuno-pathogenesis of multiple sclerosis and its animal models.
Multiple sclerosis.
Novel Targets in Multiple Sclerosis: to Oxidative Stress and Beyond.
Co-existence of tumefactive MS and hepatitis C: A need for further screening and new therapeutic challenge.
A longitudinal model for disease progression was developed and applied to multiple sclerosis.
[Criteria of ineffectiveness of treatment with first-line therapy: how to use MRI results in decision making?]
Impact of Notch1 Deletion in Macrophages on Proinflammatory Cytokine Production and the Outcome of Experimental Autoimmune Encephalomyelitis.
Structures of HSF2 reveal mechanisms for differential regulation of human heat-shock factors.
Quantifying brain tissue volume in multiple sclerosis with automated lesion segmentation and filling.
The immune response in the CNS in Theiler's virus induced demyelinating disease switches from an early adaptive response to a chronic innate-like response.
Best Practices in Alemtuzumab Administration: Practical Recommendations for Infusion in Patients With Multiple Sclerosis.
Advancing drug delivery systems for the treatment of multiple sclerosis.
Multiple sclerosis in India: An overview.
Pages
« first
‹ previous
…
475
476
477
478
479
480
481
482
483
…
next ›
last »